Horizon Discovery Group Share Price (HZD)

168.50 +0.50 (+0.30%) delayed: 12:57PM GMT
Bid price 168.00 Open price 171.28
Ask price 168.50 Prev close 168.50
High price 173.50 Spread 0.30%
Low price 168.00 Volume 193,853

Register now for FREE live Horizon Discovery Group share prices, Horizon Discovery Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Horizon Discovery Group Level 2 Data, indepth research tools and investor commentary for Horizon Discovery Group (HZD) and other London Stock Exchange equities.

Horizon Discovery Group Share Price Chart

Advanced Charts >>

Register now for FREE Horizon Discovery Group share price charts

Horizon Discovery Group Share Price Information

Name Horizon Discovery Group Epic HZD
Sector Pharmaceuticals & Biotechnology ISIN GB00BK8FL363
Activites Horizon Discovery Group plc is a world leader in gene editing and gene modulation technologies. Horizon designs and engineers cells using its translational genomics platform, a highly precise and flexible suite of DNA editing tools (rAAV, ZFN, CRISPR and Transposon) and, following the acquisition of Dharmacon, Inc., its functional genomics platform comprising gene knockdown (RNAi) and gene expression (cDNA, ORF) tools, for research and clinical applications that advance human health. Horizon's platforms and capabilities enable researchers to alter almost any gene or modulate its function in human or mammalian cell-lines. Horizon offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species and the genetic drivers of human disease and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company's own R&D pipeline. Index n/a

Horizon Discovery Group Key Numbers

Latest Share Price (p) 168.50 Net Gearing (%) -3.15
Market Capitalisation (£m) 252.56 Gross Gearing (%) 11.39
Shares in issue (m) 150.33 Debt Ratio 5.76
P/E Ratio -20.00 Debt-to-Equity Ratio 0.48
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.13
Dividend Yield (%) 0.00 Price to book value 1.48
Dividend cover (x) 0.00 ROCE (%) -7.90
Earning per share (p) -8.40 EPS Growth (%) 30.58
52 week high / low 252.00 / 128.00 DPS Growth (%) n/a

Horizon Discovery Group Director Deals

Dec.Date Type Director Pos No. of Shares
06/04/2018 BUY Richard Vellacott ED 37,830
06/04/2018 BUY Dr Jonathan Milner RES 370,000
26/03/2018 BUY Dr Jonathan Milner RES 304,000
08/02/2018 BUY Dr Darrin Disley RES 190,985
08/02/2018 BUY Dr Jonathan Milner RES 90,492

More Horizon Discovery Group Director Deals >>

Horizon Discovery Group Company News

12:17 10/12/2018

Total Voting Rights

RNS Number : 9904J Horizon Discovery Group plc 10 December 2018   10 December 2018 Horizon Discovery Group plc  Total Voting Rights In accordance with Disclosure and Transparency Rule 5.6.1 Horizon Discovery Group plc (the "Company") advises that: As at 30...

More Horizon Discovery Group Company News >>

Register now for FREE Horizon Discovery Group company news

Horizon Discovery Group Share Price Discussions

more than 1 year ago

Horizon Discovery (HZD)

Newly floated Cambridge BioTech company formed in 2007 has over 300 customers including Astra Zeneca. Floated at 180p. http://en.wikipedia.org/wiki/Horizon_Discovery

Register now for FREE Horizon Discovery Group share price discussions